Increased Survival in Low Birth Weight Neonates Given Prophylactic Surfactant

David R. Brown, Barry T. Bloom, Morris Cohen, Michael M. Myers, Edmund A. Egan, John Kattwinkel, Paula Delmore, Robert T. Hall, Michael H. Malloy, Ian R. Holzman, Waldemar A. Carlo, Arun K. Pramanik, Mary Anne McCaffree, Kathleen B. Weatherstone, Lynne D. Willett, William H. Topper

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVE: To compare the effectiveness of a prophylactic surfactant treatment strategy (PRO) to the effectiveness of a rescue (RESC) surfactant treatment strategy in patients at high risk for developing hyaline membrane disease (HMD). STUDY DESIGN: We analyzed data from a retrospective cohort consisting of all patients admitted to the neonatal intensive care units at the centers participating in the recently completed Infasurf-Survanta Comparative Trial. To be in the cohort, a patient had to be admitted during the trial, be <48 hours of age on admission, have a gestational age of <30 weeks, have a birth weight of 501 to 1250 gm, and be free of congenital anomalies. Twelve centers participated in this study. They contributed 1097 patients of whom 381 were treated with a PRO strategy. RESULTS: Survival was significantly higher in the PRO-strategy patients (84% vs 72%, p < 0.05) as was survival without oxygen requirement at a postconceptional age of 36 weeks (60% vs 46%, p < 0.05). In addition, the patients with PRO had a lower prevalence of grade III and IV intraventricular hemorrhage (IVH, 9% vs 14%, p < 0.05). All analyses were controlled for birth weight and type of study center. CONCLUSION: These data support the conclusion that using a PRO treatment strategy results in improved survival in patients at risk for developing HMD. A PRO treatment strategy may also decrease the likelihood of developing a severe IVH.

Original languageEnglish (US)
Pages (from-to)431-435
Number of pages5
JournalJournal of Perinatology
Volume18
Issue number6 SUPPL. 1
StatePublished - Nov 1 1998

Fingerprint

Low Birth Weight Infant
Surface-Active Agents
Newborn Infant
Survival
Hyaline Membrane Disease
Birth Weight
Neonatal Intensive Care Units
Therapeutics
Gestational Age
Hemorrhage
Oxygen

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Brown, D. R., Bloom, B. T., Cohen, M., Myers, M. M., Egan, E. A., Kattwinkel, J., ... Topper, W. H. (1998). Increased Survival in Low Birth Weight Neonates Given Prophylactic Surfactant. Journal of Perinatology, 18(6 SUPPL. 1), 431-435.

Increased Survival in Low Birth Weight Neonates Given Prophylactic Surfactant. / Brown, David R.; Bloom, Barry T.; Cohen, Morris; Myers, Michael M.; Egan, Edmund A.; Kattwinkel, John; Delmore, Paula; Hall, Robert T.; Malloy, Michael H.; Holzman, Ian R.; Carlo, Waldemar A.; Pramanik, Arun K.; McCaffree, Mary Anne; Weatherstone, Kathleen B.; Willett, Lynne D.; Topper, William H.

In: Journal of Perinatology, Vol. 18, No. 6 SUPPL. 1, 01.11.1998, p. 431-435.

Research output: Contribution to journalArticle

Brown, DR, Bloom, BT, Cohen, M, Myers, MM, Egan, EA, Kattwinkel, J, Delmore, P, Hall, RT, Malloy, MH, Holzman, IR, Carlo, WA, Pramanik, AK, McCaffree, MA, Weatherstone, KB, Willett, LD & Topper, WH 1998, 'Increased Survival in Low Birth Weight Neonates Given Prophylactic Surfactant', Journal of Perinatology, vol. 18, no. 6 SUPPL. 1, pp. 431-435.
Brown DR, Bloom BT, Cohen M, Myers MM, Egan EA, Kattwinkel J et al. Increased Survival in Low Birth Weight Neonates Given Prophylactic Surfactant. Journal of Perinatology. 1998 Nov 1;18(6 SUPPL. 1):431-435.
Brown, David R. ; Bloom, Barry T. ; Cohen, Morris ; Myers, Michael M. ; Egan, Edmund A. ; Kattwinkel, John ; Delmore, Paula ; Hall, Robert T. ; Malloy, Michael H. ; Holzman, Ian R. ; Carlo, Waldemar A. ; Pramanik, Arun K. ; McCaffree, Mary Anne ; Weatherstone, Kathleen B. ; Willett, Lynne D. ; Topper, William H. / Increased Survival in Low Birth Weight Neonates Given Prophylactic Surfactant. In: Journal of Perinatology. 1998 ; Vol. 18, No. 6 SUPPL. 1. pp. 431-435.
@article{44f8bab09a5246f69edb1c888bd919a2,
title = "Increased Survival in Low Birth Weight Neonates Given Prophylactic Surfactant",
abstract = "OBJECTIVE: To compare the effectiveness of a prophylactic surfactant treatment strategy (PRO) to the effectiveness of a rescue (RESC) surfactant treatment strategy in patients at high risk for developing hyaline membrane disease (HMD). STUDY DESIGN: We analyzed data from a retrospective cohort consisting of all patients admitted to the neonatal intensive care units at the centers participating in the recently completed Infasurf-Survanta Comparative Trial. To be in the cohort, a patient had to be admitted during the trial, be <48 hours of age on admission, have a gestational age of <30 weeks, have a birth weight of 501 to 1250 gm, and be free of congenital anomalies. Twelve centers participated in this study. They contributed 1097 patients of whom 381 were treated with a PRO strategy. RESULTS: Survival was significantly higher in the PRO-strategy patients (84{\%} vs 72{\%}, p < 0.05) as was survival without oxygen requirement at a postconceptional age of 36 weeks (60{\%} vs 46{\%}, p < 0.05). In addition, the patients with PRO had a lower prevalence of grade III and IV intraventricular hemorrhage (IVH, 9{\%} vs 14{\%}, p < 0.05). All analyses were controlled for birth weight and type of study center. CONCLUSION: These data support the conclusion that using a PRO treatment strategy results in improved survival in patients at risk for developing HMD. A PRO treatment strategy may also decrease the likelihood of developing a severe IVH.",
author = "Brown, {David R.} and Bloom, {Barry T.} and Morris Cohen and Myers, {Michael M.} and Egan, {Edmund A.} and John Kattwinkel and Paula Delmore and Hall, {Robert T.} and Malloy, {Michael H.} and Holzman, {Ian R.} and Carlo, {Waldemar A.} and Pramanik, {Arun K.} and McCaffree, {Mary Anne} and Weatherstone, {Kathleen B.} and Willett, {Lynne D.} and Topper, {William H.}",
year = "1998",
month = "11",
day = "1",
language = "English (US)",
volume = "18",
pages = "431--435",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "6 SUPPL. 1",

}

TY - JOUR

T1 - Increased Survival in Low Birth Weight Neonates Given Prophylactic Surfactant

AU - Brown, David R.

AU - Bloom, Barry T.

AU - Cohen, Morris

AU - Myers, Michael M.

AU - Egan, Edmund A.

AU - Kattwinkel, John

AU - Delmore, Paula

AU - Hall, Robert T.

AU - Malloy, Michael H.

AU - Holzman, Ian R.

AU - Carlo, Waldemar A.

AU - Pramanik, Arun K.

AU - McCaffree, Mary Anne

AU - Weatherstone, Kathleen B.

AU - Willett, Lynne D.

AU - Topper, William H.

PY - 1998/11/1

Y1 - 1998/11/1

N2 - OBJECTIVE: To compare the effectiveness of a prophylactic surfactant treatment strategy (PRO) to the effectiveness of a rescue (RESC) surfactant treatment strategy in patients at high risk for developing hyaline membrane disease (HMD). STUDY DESIGN: We analyzed data from a retrospective cohort consisting of all patients admitted to the neonatal intensive care units at the centers participating in the recently completed Infasurf-Survanta Comparative Trial. To be in the cohort, a patient had to be admitted during the trial, be <48 hours of age on admission, have a gestational age of <30 weeks, have a birth weight of 501 to 1250 gm, and be free of congenital anomalies. Twelve centers participated in this study. They contributed 1097 patients of whom 381 were treated with a PRO strategy. RESULTS: Survival was significantly higher in the PRO-strategy patients (84% vs 72%, p < 0.05) as was survival without oxygen requirement at a postconceptional age of 36 weeks (60% vs 46%, p < 0.05). In addition, the patients with PRO had a lower prevalence of grade III and IV intraventricular hemorrhage (IVH, 9% vs 14%, p < 0.05). All analyses were controlled for birth weight and type of study center. CONCLUSION: These data support the conclusion that using a PRO treatment strategy results in improved survival in patients at risk for developing HMD. A PRO treatment strategy may also decrease the likelihood of developing a severe IVH.

AB - OBJECTIVE: To compare the effectiveness of a prophylactic surfactant treatment strategy (PRO) to the effectiveness of a rescue (RESC) surfactant treatment strategy in patients at high risk for developing hyaline membrane disease (HMD). STUDY DESIGN: We analyzed data from a retrospective cohort consisting of all patients admitted to the neonatal intensive care units at the centers participating in the recently completed Infasurf-Survanta Comparative Trial. To be in the cohort, a patient had to be admitted during the trial, be <48 hours of age on admission, have a gestational age of <30 weeks, have a birth weight of 501 to 1250 gm, and be free of congenital anomalies. Twelve centers participated in this study. They contributed 1097 patients of whom 381 were treated with a PRO strategy. RESULTS: Survival was significantly higher in the PRO-strategy patients (84% vs 72%, p < 0.05) as was survival without oxygen requirement at a postconceptional age of 36 weeks (60% vs 46%, p < 0.05). In addition, the patients with PRO had a lower prevalence of grade III and IV intraventricular hemorrhage (IVH, 9% vs 14%, p < 0.05). All analyses were controlled for birth weight and type of study center. CONCLUSION: These data support the conclusion that using a PRO treatment strategy results in improved survival in patients at risk for developing HMD. A PRO treatment strategy may also decrease the likelihood of developing a severe IVH.

UR - http://www.scopus.com/inward/record.url?scp=0032196615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032196615&partnerID=8YFLogxK

M3 - Article

C2 - 9848755

AN - SCOPUS:0032196615

VL - 18

SP - 431

EP - 435

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 6 SUPPL. 1

ER -